DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Chlorpromazine (Chlorpromazine) - Maternal Drugs Affecting Foetus - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Maternal Drugs Affecting Foetus (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Chlorpromazine where reactions include maternal drugs affecting foetus. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Chlorpromazine side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-01-23

Patient: male, weighing 3.8 kg (8.4 pounds)

Reactions: Regurgitation, Maternal Drugs Affecting Foetus, Dystonia, Retching, Flatulence, Agitation Neonatal, Hypertonia Neonatal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Chlorpromazine
    Dosage: 75 mg daily before third quarter of pregnancy (75 mg, 1 in 1 d), transplacental, daily dose decrease

Escitalopram Oxalate
    Dosage: transplacental
    End date: 2011-11-26

Oxazepam
    Dosage: 20 mg (20 mg, 1 in 1 d), transplacental

Amitriptyline HCL
    Dosage: 1 dosage form (1 dosage forms, 1 in 1 d), transplacental

Prazepam
    Dosage: switched to oxazepam at the third quarter, transplacental



Possible Chlorpromazine side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-01-17

Patient: male, weighing 3.8 kg (8.4 pounds)

Reactions: Regurgitation, Maternal Drugs Affecting Foetus, Dystonia, Retching, Flatulence, Agitation Neonatal, Hypertonia Neonatal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: transplacental
    End date: 2011-11-26

Amitriptyline HCL
    Dosage: 1 dosage form (1 dosage forms, 1 in 1 d), transplacental

Oxazepam
    Dosage: 20 mg daily up to third quarter (20 mg, 1 in 1 d), transplacental

Prazepam
    Dosage: switched to oxazepam at the third quarter, transplacental

Chlorpromazine
    Dosage: 75 mg daily before third quarter of pregnancy (75 mg, 1 in 1 d), transplacental



Possible Chlorpromazine side effects in female

Reported by a health professional (non-physician/pharmacist) on 2011-11-01

Patient: female, weighing 1.9 kg (4.1 pounds)

Reactions: Maternal Drugs Affecting Foetus, Cleft Palate

Drug(s) suspected as cause:
Chlorpromazine
    Dosage: 25 mg, transplactal; 50 mg, transplacental
    Indication: Mental Disorder
    Start date: 2010-05-01

Chlorpromazine
    Dosage: 25 mg, transplactal; 50 mg, transplacental
    Indication: Mental Disorder
    Start date: 2010-10-05

Fluoxetine
    Dosage: 40 mg, transplacental; 20 mg, transplacental
    Indication: Mental Disorder
    Start date: 2011-04-01

Fluoxetine
    Dosage: 40 mg, transplacental; 20 mg, transplacental
    Indication: Mental Disorder
    Start date: 2011-01-17
    End date: 2011-04-01

Other drugs received by patient: Omeprazole; Paroxetine HCL; Cyclizine (Cyclizine)



Possible Chlorpromazine side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-25

Patient: female, weighing 1.9 kg (4.1 pounds)

Reactions: Maternal Drugs Affecting Foetus, Cleft Palate, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Fluoxetine
    Start date: 2011-01-17
    End date: 2011-04-01

Fluoxetine
    Start date: 2011-04-01

Chlorpromazine
    Start date: 2010-05-01

Other drugs received by patient: Omeprazole; Paroxetine HCL; Cyclizine



Possible Chlorpromazine side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-20

Patient: female, weighing 1.9 kg (4.1 pounds)

Reactions: Cleft Palate, Maternal Drugs Affecting Foetus, Maternal Alcohol Use

Drug(s) suspected as cause:
Fluoxetine Hydrochloride
    Dosage: 20 mg, transplacental, 40 mg, transplacental
    Indication: Product Used FOR Unknown Indication

Fluoxetine Hydrochloride
    Dosage: 20 mg, transplacental, 40 mg, transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-01-17
    End date: 2011-04-01

Fluoxetine Hydrochloride
    Dosage: 20 mg, transplacental, 40 mg, transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-04-01

Chlorpromazine
    Dosage: 25 mg, transplacental, 50 mg, transplacental
    Indication: Product Used FOR Unknown Indication

Chlorpromazine
    Dosage: 25 mg, transplacental, 50 mg, transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-10-05
    End date: 2011-05-01

Chlorpromazine
    Dosage: 25 mg, transplacental, 50 mg, transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01

Other drugs received by patient: Omeprazole; Paroxetine HCL; Cyclizine (Cyclizine)



Possible Chlorpromazine side effects in female

Reported by a health professional (non-physician/pharmacist) on 2011-10-20

Patient: female, weighing 1.9 kg (4.1 pounds)

Reactions: Maternal Drugs Affecting Foetus, Cleft Palate

Drug(s) suspected as cause:
Fluoxetine
    Dosage: (40 mg), transplacental (20 mg)transplacenta
    Indication: Mental Disorder
    Start date: 2011-04-01

Fluoxetine
    Dosage: (40 mg), transplacental (20 mg)transplacenta
    Indication: Mental Disorder
    Start date: 2011-01-17
    End date: 2011-04-01

Chlorpromazine
    Dosage: (25 mg), transplacental (50 mg) transplacenta
    Indication: Mental Disorder
    Start date: 2010-05-01

Chlorpromazine
    Dosage: (25 mg), transplacental (50 mg) transplacenta
    Indication: Mental Disorder
    Start date: 2010-10-05
    End date: 2011-01-01

Other drugs received by patient: Cyclizine (Cyclizine); Omeprazole; Paroxetine HCL

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017